Xiao Y, Wang J, Yang K, Jiang M, Luo J, Chen K
SAGE Open Med. 2024; 12:20503121241276683.
PMID: 39257516
PMC: 11384515.
DOI: 10.1177/20503121241276683.
Tsai D, Harmon E, Goelen J, Barry H, Chen L, Hsia Y
Pharmacy (Basel). 2024; 12(4).
PMID: 39195858
PMC: 11360832.
DOI: 10.3390/pharmacy12040129.
Kashefizadeh A, Amiri F, Ohadi L, Keikha E
Maedica (Bucur). 2024; 19(2):330-334.
PMID: 39188825
PMC: 11345044.
DOI: 10.26574/maedica.2024.19.2.330.
Espinosa-Solano M, Gonzalez-Vergara D, Ferrer-Galvan M, Asensio-Cruz M, Lomas J, Roca-Oporto C
Open Respir Arch. 2024; 3(2):100086.
PMID: 38620829
PMC: 7977067.
DOI: 10.1016/j.opresp.2021.100086.
Diaz E, Amezaga Menendez R, Vidal Cortes P, Escapa M, Suberviola B, Serrano Lazaro A
Med Intensiva. 2024; 45(2):104-121.
PMID: 38620757
PMC: 7833076.
DOI: 10.1016/j.medin.2020.06.017.
A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19.
Sharun K, Tiwari R, Yatoo M, Natesan S, Megawati D, Singh K
Narra J. 2024; 2(3):e92.
PMID: 38449903
PMC: 10914132.
DOI: 10.52225/narra.v2i3.92.
Critical Illness-Related Corticosteroid Insufficiency (CIRCI) Among Patients with COVID-19 at a Tertiary Hospital: Clinical Characteristics and Outcomes.
Arcellana A, Lim K, Arcegono M, Jimeno C
J ASEAN Fed Endocr Soc. 2023; 38(1):90-99.
PMID: 37252409
PMC: 10213165.
DOI: 10.15605/jafes.038.01.02.
Modulation of IRAK enzymes as a therapeutic strategy against SARS-CoV-2 induced cytokine storm.
Mahmoud I, Jarrar Y, Febrimarsa
Clin Exp Med. 2023; 23(6):2909-2923.
PMID: 37061574
PMC: 10105542.
DOI: 10.1007/s10238-023-01064-7.
Predicting the response to methylprednisolone pulses in patients with SARS-COV-2 infection.
Sarria-Landete A, Crespo-Matas J, Dominguez-Quesada I, Castellanos-Monedero J, Marte-Acosta D, Arias-Arias A
Med Clin (Engl Ed). 2022; 159(12):557-562.
PMID: 36536623
PMC: 9752105.
DOI: 10.1016/j.medcle.2022.02.028.
Therapeutic Strategies in the Fight against COVID-19: From Bench to Bedside.
Abadi B, Aarabi Jeshvaghani A, Fathalipour H, Dehghan L, Rahimi Sirjani K, Forootanfar H
Iran J Med Sci. 2022; 47(6):517-532.
PMID: 36380976
PMC: 9652495.
DOI: 10.30476/IJMS.2021.92662.2396.
Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options.
Nazerian Y, Ghasemi M, Yassaghi Y, Nazerian A, Hashemi S
Int Immunopharmacol. 2022; 113(Pt B):109428.
PMID: 36379152
PMC: 9637536.
DOI: 10.1016/j.intimp.2022.109428.
Inosine: A broad-spectrum anti-inflammatory against SARS-CoV-2 infection-induced acute lung injury via suppressing TBK1 phosphorylation.
Wang N, Li E, Deng H, Yue L, Zhou L, Su R
J Pharm Anal. 2022; 13(1):11-23.
PMID: 36313960
PMC: 9595505.
DOI: 10.1016/j.jpha.2022.10.002.
Immunomodulatory therapy for the management of critically ill patients with COVID-19: A narrative review.
Andaluz-Ojeda D, Vidal-Cortes P, Aparisi Sanz A, Suberviola B, Del Rio Carbajo L, Nogales Martin L
World J Crit Care Med. 2022; 11(4):269-297.
PMID: 36051937
PMC: 9305685.
DOI: 10.5492/wjccm.v11.i4.269.
COVID-19, Influenza, and Other Acute Respiratory Viral Infections: Etiology, Immunopathogenesis, Diagnosis, and Treatment. Part I. COVID-19 and Influenza.
Ilyicheva T, Netesov S, Gureyev V
Mol Gen Microbiol Virol. 2022; 37(1):1-9.
PMID: 35936505
PMC: 9342941.
DOI: 10.3103/S0891416822010025.
Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients Treated with Standard Dose of Dexamethasone or High Dose of Methylprednisolone.
Russo A, Davoli C, Borrazzo C, Olivadese V, Ceccarelli G, Fusco P
Biomedicines. 2022; 10(7).
PMID: 35884852
PMC: 9312892.
DOI: 10.3390/biomedicines10071548.
COVID-19 Pandemic and Osteoporosis in Elderly Patients.
Tang J
Aging Dis. 2022; 13(4):960-969.
PMID: 35855327
PMC: 9286914.
DOI: 10.14336/AD.2021.1201.
In-hospital mortality in SARS-CoV-2 stratified by the use of corticosteroid.
Alotaibi N, Alroomi M, Aboelhassan W, Hussein S, Rajan R, Alnasrallah N
Ann Med Surg (Lond). 2022; 80:104105.
PMID: 35784615
PMC: 9239918.
DOI: 10.1016/j.amsu.2022.104105.
Predicting the response to methylprednisolone pulses in patients with SARS-COV-2 infection.
Sarria-Landete A, Crespo-Matas J, Dominguez-Quesada I, Castellanos-Monedero J, Marte-Acosta D, Arias-Arias A
Med Clin (Barc). 2022; 159(12):557-562.
PMID: 35718548
PMC: 9212640.
DOI: 10.1016/j.medcli.2022.02.025.
Emerging Therapies for COVID-19: The Value of Information From More Clinical Trials.
Dijk S, Krijkamp E, Kunst N, Gross C, Wong J, Hunink M
Value Health. 2022; 25(8):1268-1280.
PMID: 35490085
PMC: 9045876.
DOI: 10.1016/j.jval.2022.03.016.
Effectiveness of Systemic Corticosteroids Therapy for Nonsevere Patients With COVID-19: A Multicenter, Retrospective, Longitudinal Cohort Study.
Chen Z, Yin X, Tan X, Wang J, Jiang N, Tian M
Value Health. 2022; 25(5):709-716.
PMID: 35219601
PMC: 8866099.
DOI: 10.1016/j.jval.2021.12.013.
